BEUDAMED
    14 results · 16ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Classification ×

    Diazo, Alt/Sgpt

    FDA classification
    FDA Class 1 ·Diazo, Alt/Sgpt

    Vanillin Pyruvate, Alt/Sgpt

    FDA classification
    FDA Class 1 ·Vanillin Pyruvate, Alt/Sgpt

    Hydrazone Colorimetry, Alt/Sgpt

    FDA classification
    FDA Class 1 ·Hydrazone Colorimetry, Alt/Sgpt

    Preamplifier, Ac-Powered, Ophthalmic

    FDA classification
    FDA Class 2 ·Preamplifier, Ac-Powered, Ophthalmic

    Hemagglutination, Opiates

    FDA classification
    FDA Class 2 ·Hemagglutination, Opiates

    Adaptor, Recreational

    FDA classification
    FDA Class 1 ·Adaptor, Recreational

    Ldt, Approved By Nys Clep

    FDA classification
    FDA Not Classified ·Ldt, Approved By Nys Clep

    Ivd Offered As Ldt, Not An Ldt Or Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

    FDA classification
    FDA Not Classified ·Ivd Offered As Ldt, Not An Ldt Or Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

    Nadh Oxidation/Nad Reduction, Alt/Sgpt

    FDA classification
    FDA Class 1 ·Nadh Oxidation/Nad Reduction, Alt/Sgpt

    Ldt, Not Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

    FDA classification
    FDA Not Classified ·Ldt, Not Under A Targeted Enforcement Discretion Policy Described In Preamble To Ldt Final Rule

    Ldt, Unmet Need Within An Integrated Healthcare System

    FDA classification
    FDA Not Classified ·Ldt, Unmet Need Within An Integrated Healthcare System

    Ivd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule

    FDA classification
    FDA Not Classified ·Ivd Offered As Ldt, First Marketed Before May 6, 2024, Not Modified Beyond Scope Described In Preamble To Ldt Final Rule

    Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd

    FDA classification
    FDA Not Classified ·Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd

    Modified Version Of Another Manufacturer’S Fda-Authorized Test Within Scope Described In Preamble To Ldt Final Rule

    FDA classification
    FDA Not Classified ·Modified Version Of Another Manufacturer’S Fda-Authorized Test Within Scope Described In Preamble To Ldt Final Rule